Immune Profiling Evaluation Of Newly Diagnose Multiple Myeloma (Ndmm) Transplant Eligible (Te) Patients Treated With Daratumumab, Cyclophosphamide, Thalidomide And Dexamethasone. Preliminary Results
BLOOD(2020)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要